Impact, in this context, is not a feel-good narrative; it’s a measurable one, even if more qualitatively than quantitatively in some cases. For me, it’s about which healthspan outcome is being targeted, for whom and why? How will progress be measured with replicable methods? What would count as failure? What tradeoffs are acceptable, and which ones are not? When founders and investors are aligned on these questions, capital becomes a tool for building evidence rather than amplifying narrative.
FT Weekend Print delivery
。关于这个话题，下载安装 谷歌浏览器 开启极速安全的 上网之旅。提供了深入分析
14:10, 4 марта 2026Россия
个别核心人才当然重要，但真正决定上限的，是能不能把一群密度极高的人才组织起来，让他们在同一个技术方向上持续迭代。